The pharma urgency for Belgium and Europe
Itinera calls on Belgian and European policymakers to develop a long-term innovation and growth strategy for the pharmaceutical, biotech and life sciences sector.
Itinera calls on Belgian and European policymakers to develop a long-term innovation and growth strategy for the pharmaceutical, biotech and life sciences sector.
What makes a society resilient, and why isn't resilience enough on its own? Fellow Julien De Wit examines the four pillars of societal resilience and draws concrete lessons for Belgium and Europe.
Security and defence are no longer merely a budgetary burden, but a historic opportunity: a growth engine for industry, innovation and productivity, at scale and with broad societal value.
One in five young people struggles with mental health issues. Only 45% of pupils in education are intrinsically motivated to learn new things. And functional illiteracy costs our country an estimated 2% of GDP.
Could 2026 be Europe’s year?
This country needs change, ideas and leaders who dare to turn them into action. We have stood still for too long, missed too many opportunities. And change starts with the right people around the right table, with the right network and expertise.
Last week’s European summit was, as previous summits before it, dominated by the geopolitical travails of the European Union.
The curse of Donald Trump has not failed to make its mark. After Anthony Albanese in Australia and Mark Carney in Canada, Péter Magyar wins elections in Hungary despite the open support of the American president for his opponent.